StockData
Profound Medical Corp. logo

Profound Medical Corp. (PROF) stock

PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$7.85+0.17 (+2.21%)

Close on Nov 11, 2026Market cap $286.78MP/E –Yield –

Earnings

Profound Medical's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Mar 4, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q3 FY2026
$9.80M
EPS, Q3 FY2026
$0.21
Latest guidance
Issued
Nov 5, 2026 · 2 items

Quarterly results

Revenue and earnings per share from each of Profound Medical's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Mar 4, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close$9.80M–$0.21Release
Q2 FY2026ended Jun 30, 2026Aug 6, 2026after the close$2.50M+13.6%-$0.26Release
Q1 FY2026ended Mar 31, 2026May 7, 2026after the close$5.30M+103.8%-$0.19Release
Q4 FY2025ended Dec 31, 2025Mar 5, 2026after the close$6.00M+42.9%-$0.27Release
Q3 FY2025ended Sep 30, 2025Oct 7, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Aug 14, 2025after the close$2.20M–-$0.52Release
Q1 FY2025ended Mar 31, 2025May 8, 2025after the close$2.60M–-$0.36Release
Q4 FY2024ended Dec 31, 2024Mar 7, 2025after the close$4.20M–$0.20Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Profound Medical's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
growth compared to its prior year revenueFY2026+56%–NewMay 7, 2026
revenueGAAPFY2026$25.00M––Nov 5, 2026
total revenueFY2026$25.00M$25.00MReaffirmedAug 6, 2026
gross marginGAAPFY202670%––Nov 5, 2026
gross marginFY202670%70%ReaffirmedAug 6, 2026

Guidance vs results

The last range Profound Medical gave before each report, against the figure it then reported. Full years add up the four quarters.

PeriodMetricGuidanceActualResult
Q4 FY2024Revenue$4.10M – $4.20M$4.20MWithin range

Guidance history

Every forecast Profound Medical put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026gross marginFY202670%–
Nov 5, 2026revenueFY2026$25.00M–
Aug 6, 2026gross marginFY202670%Reaffirmed
Aug 6, 2026total revenueFY2026$25.00MReaffirmed
May 7, 2026gross marginFY202670%New
May 7, 2026growth compared to its prior year revenueFY2026+56%New
May 7, 2026total revenueFY2026$25.00MNew
Oct 7, 2025Gross marginQ3 FY202572%New
Oct 7, 2025TULSA-PRO installed baseFY202575New
Oct 7, 2025total revenuesQ3 FY2025$5.20M – $5.30MNew
Aug 14, 2025total year-over-year revenue growthFY2025+70% – +75%New
Jan 8, 2025revenue growthQ4 FY2024+105% – +110%New
Jan 8, 2025total revenueQ4 FY2024$4.10M – $4.20MNew
Jan 8, 2025total revenueFY2024$11.10M – $11.20MNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Profound Medical filed with the SEC as exhibits to Form 8-K or 6-K

  1. Profound Medical to Participate in the Stifel 2026 Healthcare Conference
    Update
  2. Profound Medical Reports Strong Third Quarter 2026 Results; Expands U.S. Distribution and Positions Leadership for Next Phase of Growth
    Results
  3. Profound Medical and Cook Medical’s
    Update
  4. Emmy-Award Winning Television Host Montel Williams to Join Next ‘Let’s Huddle’ Webinar
    Update
  5. TULSA Abstracts at the 15th Interventional MRI Symposium Strengthen Real-World Evidence, Clinical Differentiation, and Platform Expansion Opportunity
    Update
  6. Profound Medical and Telix Pharmaceuticals Enter Co-Education Agreement to Advance PSMA-Informed Prostate Care
    Update
  7. Profound Medical Reports Strong Preliminary Third Quarter 2026 Revenue
    Results
  8. Profound Medical to Participate in Lake Street’s 10th Annual Best Ideas Growth Conference
    Update
  9. Profound Medical Further Strengthens Executive Leadership Team with Appointment of Richard Fabian as President
    Update
  10. Profound’s Introduction of New Real-time Interventional MRI Software Paving the Way for Full ‘TULSA Days’
    Update
  11. Profound Medical Announces Management Change
    Update
  12. Profound Medical Launches ‘Let's Huddle’, a Global Community Supporting Men Throughout Their Prostate Care Journey
    Update
  13. Profound Medical Reports Second Quarter 2026 Financial Results
    Results
  14. Robotic Radical Prostatectomy Comes Up ‘Short’ in CAPTAIN Trial
    Update
  15. Profound Medical to Release Second Quarter 2026 Financial Results on August 6th – Conference Call to Follow
    Update

See a number that looks wrong?